Stemcells (NASDAQ: STEM) reported Q4 EPS of ($0.47), $0.11 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $541 thousand versus the consensus estimate of $490 thousand.

For earnings history and earnings-related data on Stemcells (STEM) click here.

Earnings